Insider Trading & Ownership of Charles J. Homcy

Location
Palo Alto, CA
Summary
The estimated net worth of Charles J. Homcy is at least $45,280,483 dollars as of 21 Nov 2025. Charles J. Homcy is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $44M. Charles J. Homcy is the Director of Maze Therapeutics, Inc. and owns shares of Maze Therapeutics, Inc. (MAZE) stock worth about $1.28M.
Signature
/s/ Courtney Phillips, as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Charles J. Homcy and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Charles J. Homcy has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $45,280,483.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: BridgeBio Pharma, Inc. ($44,000,352).
  • Past-year value change for that position: -$13,912,443.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Charles J. Homcy

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. Director $44,000,352 -$13,912,443 -24% 08 Aug 2025
MAZE Maze Therapeutics, Inc. Director $1,280,131 19 Nov 2025
PLRX PLIANT THERAPEUTICS, INC. Director 29 Jun 2021

Insider Transactions Reported by Charles J. Homcy:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .